Related references
Note: Only part of the references are listed.Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma
Y. Shimazu et al.
GENE THERAPY (2015)
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Roger Stupp et al.
LANCET ONCOLOGY (2014)
Immunohistochemical evaluation of O6-methylguanine DNA methyltransferase (MGMT) expression in 117 cases of glioblastoma
Masaya Miyazaki et al.
NEUROPATHOLOGY (2014)
The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus
K. Fujii et al.
CANCER GENE THERAPY (2013)
Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome
Shadi Lalezari et al.
NEURO-ONCOLOGY (2013)
Double-labelling immunohistochemistry for MGMT and a cocktail of non-tumourous elements is a reliable, quick and easy technique for inferring methylation status in glioblastomas and other primary brain tumours
Elinor Burke et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2013)
Extracellular Matrix Protein CCN1 Limits Oncolytic Efficacy in Glioma
Amy Haseley et al.
CANCER RESEARCH (2012)
Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice
Adam A. Sabile et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
The Next Generation of Glioma Biomarkers: MGMT Methylation, BRAF Fusions and IDH1 Mutations
Andreas von Deimling et al.
BRAIN PATHOLOGY (2011)
Expression of cysteine-rich 61 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma
J. J. Xie et al.
EJSO (2011)
Temozolomide induced c-Myc-mediated apoptosis via Akt signalling in MGMT expressing glioblastoma cells
Maria De Salvo et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2011)
An extent of resection threshold for newly diagnosed glioblastomas
Nader Sanai et al.
JOURNAL OF NEUROSURGERY (2011)
Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis
Inamul Haque et al.
MOLECULAR CANCER (2011)
Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets
Joon-Il Jun et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Pathway inhibition: emerging molecular targets for treating glioblastoma
Wolfgang Wick et al.
NEURO-ONCOLOGY (2011)
Expression and significance of Cyr61 in distant metastasis cells of human primary salivary adenoid cystic carcinoma
Qiong-lan Tang et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2011)
MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib
Manik Chahal et al.
NEURO-ONCOLOGY (2010)
Interaction of Hypoxia-Inducible Factor-1α and Notch Signaling Regulates Medulloblastoma Precursor Proliferation and Fate
Francesca Pistollato et al.
STEM CELLS (2010)
Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma
Zhu-Qing Zhou et al.
BMC CANCER (2009)
Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype
Hidemichi Watari et al.
GYNECOLOGIC ONCOLOGY (2009)
Analysis of the IDH1 codon 132 mutation in brain tumors
Joerg Balss et al.
ACTA NEUROPATHOLOGICA (2008)
Cyr61/CCN1 and CTGF/CCN2 mediate the proangiogenic activity of VHL-mutant renal carcinoma cells
Mastan R. Chintalapudi et al.
CARCINOGENESIS (2008)
Thrombin receptor and RhoA mediate cell proliferation through integrins and cysteine-rich protein 61
Colin T. Walsh et al.
FASEB JOURNAL (2008)
A very private TGF-β receptor embrace
Joan Massague
MOLECULAR CELL (2008)
Oncolytic HSV-1 infection of tumors induces angiogenesis and upregulates CYR61
Kazuhiko Kurozumi et al.
MOLECULAR THERAPY (2008)
The CCN family of proteins: structure-function relationships
Kenneth P. Holbourn et al.
TRENDS IN BIOCHEMICAL SCIENCES (2008)
Expression of Cyr61, CTGF, and WISP-1 Correlates with Clinical Features of Lung Cancer
Ping-Ping Chen et al.
PLOS ONE (2007)
CYR61 downregulation correlates with tumor progression by promoting MMP-7 expression in human gastric carcinoma
Noritaka Maeta et al.
ONCOLOGY (2007)
Expression and regulation of CCN genes in murine osteoblasts
Muriel S. Parisi et al.
BONE (2006)
Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas
M Brell et al.
CLINICAL CANCER RESEARCH (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and β-catenin-TCF/Lef signaling pathways
D Xie et al.
CANCER RESEARCH (2004)
Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas
D Xie et al.
CLINICAL CANCER RESEARCH (2004)
Cyr61 suppresses growth of human endometrial cancer cells
WW Chien et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Biologic parameters that correlate with the prognosis of human gliomas
JV Lafuente et al.
NEUROPATHOLOGY (2000)
Share Paper
